|
|
|
Court won't hear appeal over news release
Legal News Update |
2013/12/16 11:30
|
The Supreme Court won't hear an appeal from a CEO convicted because a news release misstated the results of a drug's effectiveness.
The high court on Monday declined to hear an appeal from Dr. W. Scott Harkonen, the chief executive of the biotechnology company InterMune Inc. from 1998 until 2003. He was convicted wire fraud in the marketing of the drug Actimmune, which was supposed to fight the fatal lung disease idiopathic pulmonary fibrosis.
The conviction centered on an August 2002 news release that misstated the results of a clinical trial using Actimmune. The release falsely said the test showed Actimmune helped IPF patients live longer.
Harkonen's lawyers say the results of the trial were accurate, and he is being punished for offering a scientific opinion about the results. |
|
|
|
|
|
Intellectual Property Law |
|
|
Legal Professional Business |
|
|
Medical Malpractice Issues |
|
|
Mergers & Acquisitions Matters |
|
|
Political and Legal Trends |
|
|
Venture Business Articles |
|
|
Careers in the Legal Sector |
|
|
Legal Outlook & Information |
|
|
|
|
| © www.timelegalnews.com. All rights reserved.
The content and articles provided on this website have been prepared by Time Legal News as an informational source and service to the legal internet community and is not to act or constitute as any type of legal advice or consultation with an actual licensed attorney or legal professional in any case or circumstance.Time Legal News blog posts and comments are available for educational purposes only and should not be used to determine or valuate a legal situation or matter. Affordable Law Firm Website Design
|
|